Regulation of fibroblast growth factor receptor signalling and trafficking by Src and Eps8

Summary Fibroblast growth factor receptors (FGFRs) mediate a wide spectrum of cellular responses that are crucial for development and wound healing. However, aberrant FGFR activity leads to cancer. Activated growth factor receptors undergo stimulated endocytosis, but can continue to signal along the endocytic pathway. Endocytic trafficking controls the duration and intensity of signalling, and growth factor receptor signalling can lead to modifications of trafficking pathways. We have developed live-cell imaging methods for studying FGFR dynamics to investigate mechanisms that coordinate the interplay between receptor trafficking and signal transduction. Activated FGFR enters the cell following recruitment to pre-formed clathrin-coated pits (CCPs). However, FGFR activation stimulates clathrin-mediated endocytosis; FGF treatment increases the number of CCPs, including those undergoing endocytosis, and this effect is mediated by Src and its phosphorylation target Eps8. Eps8 interacts with the clathrin-mediated endocytosis machinery and depletion of Eps8 inhibits FGFR trafficking and immediate Erk signalling. Once internalized, FGFR passes through peripheral early endosomes en route to recycling and degredative compartments, through an Src- and Eps8-dependent mechanism. Thus Eps8 functions as a key coordinator in the interplay between FGFR signalling and trafficking. This work provides the first detailed mechanistic analysis of growth factor receptor clustering at the cell surface through signal transduction and endocytic trafficking. As we have characterised the Src target Eps8 as a key regulator of FGFR signalling and trafficking, and identified the early endocytic system as the site of Eps8-mediated effects, this work provides novel mechanistic insight into the reciprocal regulation of growth factor receptor signalling and trafficking.

[1]  R. Vale,et al.  Total Internal Reflection Fluorescence Microscopy. , 2015, Cold Spring Harbor protocols.

[2]  A. Choi,et al.  Caveolin-1 Inhibits Expression of Antioxidant Enzymes through Direct Interaction with Nuclear Erythroid 2 p45-related Factor-2 (Nrf2)* , 2012, The Journal of Biological Chemistry.

[3]  M. Rossner,et al.  Regulation of the EGF Transcriptional Response by Endocytic Sorting , 2012, Science Signaling.

[4]  Hongying Shen,et al.  Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane , 2012, Proceedings of the National Academy of Sciences.

[5]  H. Stenmark,et al.  Endocytosis and signaling. , 2011, Current opinion in cell biology.

[6]  J. Wesche,et al.  Fibroblast growth factors and their receptors in cancer. , 2011, The Biochemical journal.

[7]  A. Brech,et al.  Clathrin- and Dynamin-Independent Endocytosis of FGFR3 – Implications for Signalling , 2011, PloS one.

[8]  D. Perrais,et al.  A High Precision Survey of the Molecular Dynamics of Mammalian Clathrin-Mediated Endocytosis , 2011, Microscopy and Microanalysis.

[9]  S. Simon,et al.  Imaging with total internal reflection fluorescence microscopy for the cell biologist , 2010, Journal of Cell Science.

[10]  H. Cooper,et al.  Differential Phosphoproteomics of Fibroblast Growth Factor Signaling: Identification of Src Family Kinase-Mediated Phosphorylation Events , 2010, Journal of proteome research.

[11]  N. Turner,et al.  Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.

[12]  G. Scita,et al.  Endocytosis and spatial restriction of cell signaling , 2009, Molecular oncology.

[13]  H. McMahon,et al.  Mechanisms of endocytosis. , 2009, Annual review of biochemistry.

[14]  S. Simon,et al.  Endocytic trafficking of activated EGFR is AP-2 dependent and occurs through preformed clathrin spots , 2009, Journal of Cell Science.

[15]  M. Mohammadi,et al.  The FGF family: biology, pathophysiology and therapy , 2009, Nature Reviews Drug Discovery.

[16]  Klaus Suhling,et al.  Indirect recruitment of the signalling adaptor Shc to the fibroblast growth factor receptor 2 (FGFR2). , 2008, The Biochemical journal.

[17]  M. Frame,et al.  Endosomal trafficking of Src tyrosine kinase. , 2008, Trends in cell biology.

[18]  C. Tregidgo,et al.  Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling. , 2008, The Biochemical journal.

[19]  J. Rappoport,et al.  Focusing on clathrin-mediated endocytosis. , 2008, The Biochemical journal.

[20]  S. Simon,et al.  A Functional GFP Fusion for Imaging Clathrin‐Mediated Endocytosis , 2008, Traffic.

[21]  John K Heath,et al.  Src kinase modulates the activation, transport and signalling dynamics of fibroblast growth factor receptors , 2007, EMBO reports.

[22]  F. Belleudi,et al.  Keratinocyte Growth Factor Receptor Ligands Target the Receptor to Different Intracellular Pathways , 2007, Traffic.

[23]  M. von Zastrow,et al.  Signaling on the endocytic pathway. , 2007, Current opinion in cell biology.

[24]  Andrea Disanza,et al.  Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8–IRSp53 complex , 2006, Nature Cell Biology.

[25]  T. Kirchhausen,et al.  Dynasore, a cell-permeable inhibitor of dynamin. , 2006, Developmental cell.

[26]  S. Polo,et al.  Endocytosis Conducts the Cell Signaling Orchestra , 2006, Cell.

[27]  C. Dickson,et al.  Fibroblast growth factor signaling in tumorigenesis. , 2005, Cytokine & growth factor reviews.

[28]  Jeffrey L. Wrana,et al.  Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling , 2005, Nature Reviews Molecular Cell Biology.

[29]  Morag Park,et al.  Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases. , 2003, Cancer cell.

[30]  Giorgio Scita,et al.  Eps8 in the midst of GTPases. , 2002, The international journal of biochemistry & cell biology.

[31]  Mark von Zastrow,et al.  Signal transduction and endocytosis: close encounters of many kinds , 2002, Nature Reviews Molecular Cell Biology.

[32]  Boris N Kholodenko,et al.  MAP kinase cascade signaling and endocytic trafficking: a marriage of convenience? , 2002, Trends in cell biology.

[33]  David G. Drubin,et al.  The actin-binding protein Hip1R associates with clathrin during early stages of endocytosis and promotes clathrin assembly in vitro , 2001, The Journal of cell biology.

[34]  P. Camilli,et al.  Endocytosis and Signaling An Inseparable Partnership , 2001, Cell.

[35]  Pier Paolo Di Fiore,et al.  The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5 , 2000, Nature.

[36]  Bevil R. Conway,et al.  Cell Surface Trk Receptors Mediate NGF-Induced Survival While Internalized Receptors Regulate NGF-Induced Differentiation , 2000, The Journal of Neuroscience.

[37]  G. Mcmahon,et al.  Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. , 1999, Journal of medicinal chemistry.

[38]  J. Wesche,et al.  Uptake and intracellular transport of acidic fibroblast growth factor: evidence for free and cytoskeleton-anchored fibroblast growth factor receptors. , 1999, Molecular biology of the cell.

[39]  F. Brodsky,et al.  EGF Receptor Signaling Stimulates SRC Kinase Phosphorylation of Clathrin, Influencing Clathrin Redistribution and EGF Uptake , 1999, Cell.

[40]  L. Frati,et al.  Receptor-mediated endocytosis of keratinocyte growth factor. , 1998, Journal of cell science.

[41]  R. Carbone,et al.  Eps8, a tyrosine kinase substrate, is recruited to the cell cortex and dynamic F-actin upon cytoskeleton remodeling. , 1998, Experimental cell research.

[42]  Russ P Carstens,et al.  Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer , 1997, Oncogene.

[43]  M. Zerial,et al.  Rab11 regulates recycling through the pericentriolar recycling endosome , 1996, The Journal of cell biology.

[44]  P. Gleizes,et al.  Basic fibroblast growth factor (FGF-2) is addressed to caveolae after binding to the plasma membrane of BHK cells. , 1996, European journal of cell biology.

[45]  Rein Aasland,et al.  Endosomal Localization of the Autoantigen EEA1 Is Mediated by a Zinc-binding FYVE Finger* , 1996, The Journal of Biological Chemistry.

[46]  C. Heldin,et al.  Dimerization of cell surface receptors in signal transduction , 1995, Cell.

[47]  I. Mason.  The ins and outs of fibroblast growth factors , 1994, Cell.

[48]  Richard G. W. Anderson,et al.  Caveolin, a protein component of caveolae membrane coats , 1992, Cell.

[49]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[50]  M. Waterfield,et al.  Epidermal growth factor binding induces a conformational change in the external domain of its receptor. , 1989, The EMBO journal.

[51]  I. Pastan,et al.  Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Carpenter,et al.  Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts , 1984, The Journal of cell biology.

[53]  D. Axelrod.  Chapter 7: Total internal reflection fluorescence microscopy. , 2008, Methods in cell biology.

[54]  L. Pelkmans,et al.  Clathrin- and caveolin-1–independent endocytosis: entry of simian virus 40 into cells devoid of caveolae , 2005 .

[55]  D. Moscatelli,et al.  The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.

[56]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.